Psychedelics as Standard of Care? Many Questions Remain
K. Rasmussen, D. Olson
Cambridge Quarterly of Healthcare Ethics October 1, 2022 DOI: 10.1017/s096318012200010x (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Peer reviewed |
|---|---|
| Citations | 9 |
Abstract
An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Citations in the library
Cited by 10
- Psychedelics, Meaningfulness, and the "Proper Scope" of Medicine: Continuing the Conversation. Cambridge Quarterly of Healthcare Ethics June 27, 2023
- Is the Requirement for First-Person Experience of Psychedelic Drugs a Justified Component of a Psychedelic Therapist's Training? Cambridge Quarterly of Healthcare Ethics March 2, 2023
- A Transformative Trip? Experiences of Psychedelic Use Neuroethics June 20, 2024
- Ethical Aspects of Psychedelic-Assisted Treatments: An Overview. Current Topics in Behavioral Neurosciences November 8, 2024
- Artificial intelligence and psychedelic medicine Annals of the New York Academy of Sciences September 23, 2024
and 5 more in the library